Advertisement
Advertisement

GLTO

GLTO logo

Galecto Inc

4.86
USD
-0.38
-7.25%
Dec 18, 15:40 UTC -5
Closed
...

Galecto Inc Profile

About

Galecto Inc. is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis. Galecto Inc. is headquarters in Copenhagen, Denmark.

Info & Links

CEO

Hans T. Schambye

Headquarters

75 STATE STREET,SUITE 100
BOSTON, MA 02109, DENMARK

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.galecto.com

Auditor

EY Godkendt Revisionspartnerselskab

Share holders

23

Employees

13

Galecto Inc Statistics

Valuation Measures

Market Capitalization2

6.42M

Enterprise Value

-13.26M

Enterprise Value/EBITDA(ttm)

0.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.32

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-76.96%

Return on Invested Capital(ttm)

-80.66%

Return on Assets(ttm)

-66.59%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-21.74M

Net Income Available to Common(ttm)

-21.17M

Diluted EPS(ttm)

-19.14

Share Statistics

Beta (5Y Monthly)

1.15

52-Week Change

-68.80%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.32M

Dividend Yield

0.00%

Float4

1.16M

% Held by Insiders

11.90%

% Held by Institutions

14.20%

Balance Sheet

Total Cash(mrq)

19.68M

Total Cash Per Share(mrq)

14.94

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.68%

Quick Ratio(mrq)

8.68%

Book Value Per Share(mrq)

16.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-11.95

Free Cash Flow(ytd)

-13.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement